MEDFORD, N.Y., April 26, 2018 -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it will release financial results for the first quarter 2018 after the close of trading on Wednesday, May 9, 2018. The Company’s management team will host a corresponding conference call beginning at 4:30 pm ET.
Investors interested in listening to the conference call may do so by dialing 877-407-0778 from the US or 201-689-8565 from outside the US. A live and archived webcast of the event will be available on the “Investors” section of the Company’s website at www.chembio.com. A telephone replay will be available by dialing 877-481-4010 from the US or 919-882-2331 from outside the US using passcode 28132 until 4:30pm ET on Wednesday, May 16, 2018.
Contact:
Lynn Pieper Lewis
Gilmartin Group
Investor Relations
(415) 937-5402
[email protected]


OpenAI Hires OpenClaw Creator Peter Steinberger to Advance Next-Generation AI Agents
Goldman Sachs Reportedly Drops Diversity Criteria From Board Candidate Evaluations
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle
Anthropic’s Claude AI Reportedly Used in U.S. Operation to Capture Nicolas Maduro
AstroTurf Expands Footprint at Colorado as Buffaloes Complete Second Installation in 12 Months
Anduril Industries Seeks $8 Billion Funding at $60 Billion Valuation
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease
Vietnam Approves SpaceX Starlink Satellite Internet Service Amid U.S. Trade Talks
Freedom Finance and Binance Join Forces in Digital Assets
Starboard Value Targets Tripadvisor Board Overhaul Amid Stock Slump
Federal Court Fines Mobil Oil Australia A$16 Million for Misleading Fuel Claims
Mitsui Kinzoku Stock Surges to Record High After Profit Forecast Upgrade and Dividend Increase
Warner Bros. Discovery Weighs Renewed Sale Talks With Paramount Skydance Amid Netflix Deal Review
Anderson Cooper to Exit CBS News’ 60 Minutes After Nearly 20 Years
Disney Issues Cease-and-Desist to ByteDance Over Alleged AI Copyright Infringement
Luxury Stocks Face Volatility as AI Market Swings and Hedge Fund Bets Rattle LVMH and Kering 



